Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET

Purpose: A dosimetric study was conducted to compare intracavitary brachytherapy using both a conventional and a custom loading intended to cover a positron emission tomography (PET)-defined tumor volume in patients with cervix cancer. Methods and Materials: Eleven patients who underwent an [18 F]-f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation oncology, biology, physics biology, physics, 2007, Vol.67 (1), p.91-96
Hauptverfasser: Lin, Lilie L., M.D, Mutic, Sasa, B.S, Low, Daniel A., Ph.D, LaForest, Richard, Ph.D, Vicic, Milos, Ph.D, Zoberi, Imran, M.D, Miller, Tom R., M.D., Ph.D, Grigsby, Perry W., M.D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 96
container_issue 1
container_start_page 91
container_title International journal of radiation oncology, biology, physics
container_volume 67
creator Lin, Lilie L., M.D
Mutic, Sasa, B.S
Low, Daniel A., Ph.D
LaForest, Richard, Ph.D
Vicic, Milos, Ph.D
Zoberi, Imran, M.D
Miller, Tom R., M.D., Ph.D
Grigsby, Perry W., M.D
description Purpose: A dosimetric study was conducted to compare intracavitary brachytherapy using both a conventional and a custom loading intended to cover a positron emission tomography (PET)-defined tumor volume in patients with cervix cancer. Methods and Materials: Eleven patients who underwent an [18 F]-fluoro-deoxy-D-glucose (FDG)-PET in conjunction with their first, middle, or last brachytherapy treatment were included in this prospective study. A standard plan that delivers 6.5 Gy to point A under ideal conditions was compared with an optimized plan designed to conform the 6.5-Gy isodose surface to the PET defined volume. Results: A total of 31 intracavitary brachytherapy treatments in conjunction with an FDG-PET were performed. The percent coverage of the target isodose surface for the first implant with and without optimization was 73% and 68% ( p = 0.21). The percent coverage of the target isodose surface for the mid/final implant was 83% and 70% ( p = 0.02), respectively. The dose to point A was higher with the optimized plans for both the first implant ( p = 0.02) and the mid/last implants ( p = 0.008). The dose to 2 cm3 and 5 cm3 of both the bladder and rectum were not significantly different. Conclusions: FDG-PET based treatment planning allowed for improved dose coverage of the tumor without significantly increasing the dose to the bladder and rectum.
doi_str_mv 10.1016/j.ijrobp.2006.08.017
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_20850299</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0360301606027337</els_id><sourcerecordid>68374471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c509t-5c9c1af13922ef3bd7f61f2756951c2b00a9a87c3cd456c39b139574d6e7f6223</originalsourceid><addsrcrecordid>eNqFkVGL1DAQx4Mo3nr6DUQKgm-tk6RNmhfhOO9O8UDBE3wLaTp1U7ttL0kX9tub0gXBF58SyG_-mfkNIa8pFBSoeN8XrvdTMxcMQBRQF0DlE7KjtVQ5r6qfT8kOuICcJ_iCvAihBwBKZfmcXFBJawVC7MiXq9bM0R0xa7yx-1PcozfzKYseTTzgGLN5MOPoxl9ZN_nMoj86a4bMmjHdsyWsL7cf7_JvNw8vybPODAFfnc9L8uP25uH6U37_9e7z9dV9bitQMa-sstR0lCvGsONNKztBOyYroSpqWQNglKml5bYtK2G5ahJaybIVmEjG-CV5u-VOITodrIto93YaR7RRM6grYEol6t1GzX56XDBEfXDB4pDGwWkJWtRclqWkCSw30PopBI-dnr07GH_SFPSqWvd6U61X1RpqnVSnsjfn_KU5YPu36Ow2AR82AJOLo0O_topJW-v82mk7uf_98G-AHdy46v-NJwz9tPgxedZUB6ZBf1_XvW4bBDDJueR_ABLfpSI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68374471</pqid></control><display><type>article</type><title>Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lin, Lilie L., M.D ; Mutic, Sasa, B.S ; Low, Daniel A., Ph.D ; LaForest, Richard, Ph.D ; Vicic, Milos, Ph.D ; Zoberi, Imran, M.D ; Miller, Tom R., M.D., Ph.D ; Grigsby, Perry W., M.D</creator><creatorcontrib>Lin, Lilie L., M.D ; Mutic, Sasa, B.S ; Low, Daniel A., Ph.D ; LaForest, Richard, Ph.D ; Vicic, Milos, Ph.D ; Zoberi, Imran, M.D ; Miller, Tom R., M.D., Ph.D ; Grigsby, Perry W., M.D</creatorcontrib><description>Purpose: A dosimetric study was conducted to compare intracavitary brachytherapy using both a conventional and a custom loading intended to cover a positron emission tomography (PET)-defined tumor volume in patients with cervix cancer. Methods and Materials: Eleven patients who underwent an [18 F]-fluoro-deoxy-D-glucose (FDG)-PET in conjunction with their first, middle, or last brachytherapy treatment were included in this prospective study. A standard plan that delivers 6.5 Gy to point A under ideal conditions was compared with an optimized plan designed to conform the 6.5-Gy isodose surface to the PET defined volume. Results: A total of 31 intracavitary brachytherapy treatments in conjunction with an FDG-PET were performed. The percent coverage of the target isodose surface for the first implant with and without optimization was 73% and 68% ( p = 0.21). The percent coverage of the target isodose surface for the mid/final implant was 83% and 70% ( p = 0.02), respectively. The dose to point A was higher with the optimized plans for both the first implant ( p = 0.02) and the mid/last implants ( p = 0.008). The dose to 2 cm3 and 5 cm3 of both the bladder and rectum were not significantly different. Conclusions: FDG-PET based treatment planning allowed for improved dose coverage of the tumor without significantly increasing the dose to the bladder and rectum.</description><identifier>ISSN: 0360-3016</identifier><identifier>EISSN: 1879-355X</identifier><identifier>DOI: 10.1016/j.ijrobp.2006.08.017</identifier><identifier>PMID: 17189066</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; BLADDER ; BRACHYTHERAPY ; Brachytherapy - methods ; CARCINOMAS ; cervix ; Feasibility Studies ; Female ; FLUORINE 18 ; Fluorodeoxyglucose F18 ; GLUCOSE ; Hematology, Oncology and Palliative Medicine ; Humans ; Image Processing, Computer-Assisted - methods ; Middle Aged ; OPTIMIZATION ; PATIENTS ; PET ; PLANNING ; POSITRON COMPUTED TOMOGRAPHY ; Positron-Emission Tomography ; Prospective Studies ; RADIATION DOSES ; RADIATION SOURCE IMPLANTS ; Radiology ; RADIOLOGY AND NUCLEAR MEDICINE ; Radiopharmaceuticals ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted - methods ; RECTUM ; treatment planning ; Uterine Cervical Neoplasms - diagnostic imaging ; Uterine Cervical Neoplasms - radiotherapy</subject><ispartof>International journal of radiation oncology, biology, physics, 2007, Vol.67 (1), p.91-96</ispartof><rights>Elsevier Inc.</rights><rights>2007 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c509t-5c9c1af13922ef3bd7f61f2756951c2b00a9a87c3cd456c39b139574d6e7f6223</citedby><cites>FETCH-LOGICAL-c509t-5c9c1af13922ef3bd7f61f2756951c2b00a9a87c3cd456c39b139574d6e7f6223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijrobp.2006.08.017$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,777,781,882,3538,4011,27905,27906,27907,45977</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17189066$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/20850299$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Lin, Lilie L., M.D</creatorcontrib><creatorcontrib>Mutic, Sasa, B.S</creatorcontrib><creatorcontrib>Low, Daniel A., Ph.D</creatorcontrib><creatorcontrib>LaForest, Richard, Ph.D</creatorcontrib><creatorcontrib>Vicic, Milos, Ph.D</creatorcontrib><creatorcontrib>Zoberi, Imran, M.D</creatorcontrib><creatorcontrib>Miller, Tom R., M.D., Ph.D</creatorcontrib><creatorcontrib>Grigsby, Perry W., M.D</creatorcontrib><title>Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET</title><title>International journal of radiation oncology, biology, physics</title><addtitle>Int J Radiat Oncol Biol Phys</addtitle><description>Purpose: A dosimetric study was conducted to compare intracavitary brachytherapy using both a conventional and a custom loading intended to cover a positron emission tomography (PET)-defined tumor volume in patients with cervix cancer. Methods and Materials: Eleven patients who underwent an [18 F]-fluoro-deoxy-D-glucose (FDG)-PET in conjunction with their first, middle, or last brachytherapy treatment were included in this prospective study. A standard plan that delivers 6.5 Gy to point A under ideal conditions was compared with an optimized plan designed to conform the 6.5-Gy isodose surface to the PET defined volume. Results: A total of 31 intracavitary brachytherapy treatments in conjunction with an FDG-PET were performed. The percent coverage of the target isodose surface for the first implant with and without optimization was 73% and 68% ( p = 0.21). The percent coverage of the target isodose surface for the mid/final implant was 83% and 70% ( p = 0.02), respectively. The dose to point A was higher with the optimized plans for both the first implant ( p = 0.02) and the mid/last implants ( p = 0.008). The dose to 2 cm3 and 5 cm3 of both the bladder and rectum were not significantly different. Conclusions: FDG-PET based treatment planning allowed for improved dose coverage of the tumor without significantly increasing the dose to the bladder and rectum.</description><subject>Adult</subject><subject>Aged</subject><subject>BLADDER</subject><subject>BRACHYTHERAPY</subject><subject>Brachytherapy - methods</subject><subject>CARCINOMAS</subject><subject>cervix</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>FLUORINE 18</subject><subject>Fluorodeoxyglucose F18</subject><subject>GLUCOSE</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Image Processing, Computer-Assisted - methods</subject><subject>Middle Aged</subject><subject>OPTIMIZATION</subject><subject>PATIENTS</subject><subject>PET</subject><subject>PLANNING</subject><subject>POSITRON COMPUTED TOMOGRAPHY</subject><subject>Positron-Emission Tomography</subject><subject>Prospective Studies</subject><subject>RADIATION DOSES</subject><subject>RADIATION SOURCE IMPLANTS</subject><subject>Radiology</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>Radiopharmaceuticals</subject><subject>Radiotherapy Dosage</subject><subject>Radiotherapy Planning, Computer-Assisted - methods</subject><subject>RECTUM</subject><subject>treatment planning</subject><subject>Uterine Cervical Neoplasms - diagnostic imaging</subject><subject>Uterine Cervical Neoplasms - radiotherapy</subject><issn>0360-3016</issn><issn>1879-355X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkVGL1DAQx4Mo3nr6DUQKgm-tk6RNmhfhOO9O8UDBE3wLaTp1U7ttL0kX9tub0gXBF58SyG_-mfkNIa8pFBSoeN8XrvdTMxcMQBRQF0DlE7KjtVQ5r6qfT8kOuICcJ_iCvAihBwBKZfmcXFBJawVC7MiXq9bM0R0xa7yx-1PcozfzKYseTTzgGLN5MOPoxl9ZN_nMoj86a4bMmjHdsyWsL7cf7_JvNw8vybPODAFfnc9L8uP25uH6U37_9e7z9dV9bitQMa-sstR0lCvGsONNKztBOyYroSpqWQNglKml5bYtK2G5ahJaybIVmEjG-CV5u-VOITodrIto93YaR7RRM6grYEol6t1GzX56XDBEfXDB4pDGwWkJWtRclqWkCSw30PopBI-dnr07GH_SFPSqWvd6U61X1RpqnVSnsjfn_KU5YPu36Ow2AR82AJOLo0O_topJW-v82mk7uf_98G-AHdy46v-NJwz9tPgxedZUB6ZBf1_XvW4bBDDJueR_ABLfpSI</recordid><startdate>2007</startdate><enddate>2007</enddate><creator>Lin, Lilie L., M.D</creator><creator>Mutic, Sasa, B.S</creator><creator>Low, Daniel A., Ph.D</creator><creator>LaForest, Richard, Ph.D</creator><creator>Vicic, Milos, Ph.D</creator><creator>Zoberi, Imran, M.D</creator><creator>Miller, Tom R., M.D., Ph.D</creator><creator>Grigsby, Perry W., M.D</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>2007</creationdate><title>Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET</title><author>Lin, Lilie L., M.D ; Mutic, Sasa, B.S ; Low, Daniel A., Ph.D ; LaForest, Richard, Ph.D ; Vicic, Milos, Ph.D ; Zoberi, Imran, M.D ; Miller, Tom R., M.D., Ph.D ; Grigsby, Perry W., M.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c509t-5c9c1af13922ef3bd7f61f2756951c2b00a9a87c3cd456c39b139574d6e7f6223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>BLADDER</topic><topic>BRACHYTHERAPY</topic><topic>Brachytherapy - methods</topic><topic>CARCINOMAS</topic><topic>cervix</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>FLUORINE 18</topic><topic>Fluorodeoxyglucose F18</topic><topic>GLUCOSE</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Image Processing, Computer-Assisted - methods</topic><topic>Middle Aged</topic><topic>OPTIMIZATION</topic><topic>PATIENTS</topic><topic>PET</topic><topic>PLANNING</topic><topic>POSITRON COMPUTED TOMOGRAPHY</topic><topic>Positron-Emission Tomography</topic><topic>Prospective Studies</topic><topic>RADIATION DOSES</topic><topic>RADIATION SOURCE IMPLANTS</topic><topic>Radiology</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>Radiopharmaceuticals</topic><topic>Radiotherapy Dosage</topic><topic>Radiotherapy Planning, Computer-Assisted - methods</topic><topic>RECTUM</topic><topic>treatment planning</topic><topic>Uterine Cervical Neoplasms - diagnostic imaging</topic><topic>Uterine Cervical Neoplasms - radiotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lin, Lilie L., M.D</creatorcontrib><creatorcontrib>Mutic, Sasa, B.S</creatorcontrib><creatorcontrib>Low, Daniel A., Ph.D</creatorcontrib><creatorcontrib>LaForest, Richard, Ph.D</creatorcontrib><creatorcontrib>Vicic, Milos, Ph.D</creatorcontrib><creatorcontrib>Zoberi, Imran, M.D</creatorcontrib><creatorcontrib>Miller, Tom R., M.D., Ph.D</creatorcontrib><creatorcontrib>Grigsby, Perry W., M.D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>International journal of radiation oncology, biology, physics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Lilie L., M.D</au><au>Mutic, Sasa, B.S</au><au>Low, Daniel A., Ph.D</au><au>LaForest, Richard, Ph.D</au><au>Vicic, Milos, Ph.D</au><au>Zoberi, Imran, M.D</au><au>Miller, Tom R., M.D., Ph.D</au><au>Grigsby, Perry W., M.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET</atitle><jtitle>International journal of radiation oncology, biology, physics</jtitle><addtitle>Int J Radiat Oncol Biol Phys</addtitle><date>2007</date><risdate>2007</risdate><volume>67</volume><issue>1</issue><spage>91</spage><epage>96</epage><pages>91-96</pages><issn>0360-3016</issn><eissn>1879-355X</eissn><abstract>Purpose: A dosimetric study was conducted to compare intracavitary brachytherapy using both a conventional and a custom loading intended to cover a positron emission tomography (PET)-defined tumor volume in patients with cervix cancer. Methods and Materials: Eleven patients who underwent an [18 F]-fluoro-deoxy-D-glucose (FDG)-PET in conjunction with their first, middle, or last brachytherapy treatment were included in this prospective study. A standard plan that delivers 6.5 Gy to point A under ideal conditions was compared with an optimized plan designed to conform the 6.5-Gy isodose surface to the PET defined volume. Results: A total of 31 intracavitary brachytherapy treatments in conjunction with an FDG-PET were performed. The percent coverage of the target isodose surface for the first implant with and without optimization was 73% and 68% ( p = 0.21). The percent coverage of the target isodose surface for the mid/final implant was 83% and 70% ( p = 0.02), respectively. The dose to point A was higher with the optimized plans for both the first implant ( p = 0.02) and the mid/last implants ( p = 0.008). The dose to 2 cm3 and 5 cm3 of both the bladder and rectum were not significantly different. Conclusions: FDG-PET based treatment planning allowed for improved dose coverage of the tumor without significantly increasing the dose to the bladder and rectum.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>17189066</pmid><doi>10.1016/j.ijrobp.2006.08.017</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0360-3016
ispartof International journal of radiation oncology, biology, physics, 2007, Vol.67 (1), p.91-96
issn 0360-3016
1879-355X
language eng
recordid cdi_osti_scitechconnect_20850299
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Aged
BLADDER
BRACHYTHERAPY
Brachytherapy - methods
CARCINOMAS
cervix
Feasibility Studies
Female
FLUORINE 18
Fluorodeoxyglucose F18
GLUCOSE
Hematology, Oncology and Palliative Medicine
Humans
Image Processing, Computer-Assisted - methods
Middle Aged
OPTIMIZATION
PATIENTS
PET
PLANNING
POSITRON COMPUTED TOMOGRAPHY
Positron-Emission Tomography
Prospective Studies
RADIATION DOSES
RADIATION SOURCE IMPLANTS
Radiology
RADIOLOGY AND NUCLEAR MEDICINE
Radiopharmaceuticals
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted - methods
RECTUM
treatment planning
Uterine Cervical Neoplasms - diagnostic imaging
Uterine Cervical Neoplasms - radiotherapy
title Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T10%3A21%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adaptive%20brachytherapy%20treatment%20planning%20for%20cervical%20cancer%20using%20FDG-PET&rft.jtitle=International%20journal%20of%20radiation%20oncology,%20biology,%20physics&rft.au=Lin,%20Lilie%20L.,%20M.D&rft.date=2007&rft.volume=67&rft.issue=1&rft.spage=91&rft.epage=96&rft.pages=91-96&rft.issn=0360-3016&rft.eissn=1879-355X&rft_id=info:doi/10.1016/j.ijrobp.2006.08.017&rft_dat=%3Cproquest_osti_%3E68374471%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68374471&rft_id=info:pmid/17189066&rft_els_id=S0360301606027337&rfr_iscdi=true